Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-11T08:52:48.873Z Has data issue: false hasContentIssue false
  • English
  • Français

Somatostatin analogues have no role in the treatment of advanced differentiated thyroid cancer

Published online by Cambridge University Press:  08 March 2006

O. Alhamarneh ,
J. Murphy ,
S.L. Atkin  and
R.J.A. England
O. Alhamarneh
Affiliation:
Department of Otolaryngology Head and Neck Surgery, Hull Royal Infirmary, Hull, UK.
J. Murphy
Affiliation:
Department of Otolaryngology Head and Neck Surgery, Hull Royal Infirmary, Hull, UK.
S.L. Atkin
Affiliation:
Department of Otolaryngology Head and Neck Surgery, Hull Royal Infirmary, Hull, UK.
R.J.A. England
Affiliation:
Department of Otolaryngology Head and Neck Surgery, Hull Royal Infirmary, Hull, UK.
Get access Rights & Permissions [Opens in a new window]

Abstract

Somatostatins are neuropeptides that have a downregulatory effect on various physiological processes. Their use in the management of certain endocrine tumours is well recognized. Their use in thyroid cancer is not established, although there is some evidence to suggest that they have a role in advanced metastatic disease. We report a case of a patient with advanced metastatic follicular thyroid cancer which demonstrated strong octreotide uptake with reduced avidity for I131. Treatment with the somatostatin analogue octreotide, however, failed to achieve a significant response. We feel this case is important as it suggests that although octreotide provides a useful further imaging modality in differentiated thyroid cancer, it has no therapeutic role.

Keywords

SomatostatinThyroid Neoplasms
Type
Research Article
Information
The Journal of Laryngology & Otology , Volume 118 , Issue 8 , August 2004 , pp. 653 - 654
Copyright
© 2004 Royal Society of Medicine Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)